RxDoctor Payments Data

Matthew Owen, MD

Orthopaedic Surgery · Birmingham, ALNPI 1760827901

Payments from drug & device makers

What this record shows

This record is dominated by grants: $24,375 of the $38,027 with a category attached, or 64.1%. Arthrex accounts for 69.8% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $32,818 and has fallen 99.3% since, to $229 in 2025. Among orthopaedic surgery clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$38,027in general payments, 2019–2025

Across 80 payments — averaging $475.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$27K
  • DJO, LLC$4K
  • Smith+Nephew$3K
  • Prime Surgical, LLC$2K
  • Stryker$1K
  • Lima USA, Inc.$653
  • plus $882 from 12 others

What the payments were for

  • Grants$24,37564%
  • Travel & lodging$2,8698%
  • Food & beverage$3,71010%
  • Education$6,97918%
  • Gifts$940%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$38,027 in reported general payments places this provider in the 90th percentile of 319 orthopaedic surgery providers in Alabama.

See all orthopaedic surgery providers in Alabama

Medicare billing

Part B allowed, 2024
$169,896
Medicare patients
386
Services billed
9,103

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen245$2,014
Methocarbamol128$1,273
Ondansetron Hcl113$531
Cephalexin92$294
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen20$172
Meloxicam65$157
Tramadol Hcl30$73
Clindamycin Hcl14$65

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →